A retrospective, single-center Study analysing safetyand efficacy of Pimavanserin in patients with Parkinson's Disease
Latest Information Update: 11 Jun 2021
At a glance
- Drugs Pimavanserin (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions; Therapeutic Use
- 11 Jun 2021 New trial record
- 22 Apr 2021 Results presented at the 73rd Annual Meeting of the American Academy of Neurology